

The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism around its depression treatment.
You can purchase shares of NRX Pharmaceuticals (NASDAQ:NRXP) through any online brokerage.
Other companies in NRX Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
NRX Pharmaceuticals has a consensus price target of $29.57.
The stock price for NRX Pharmaceuticals (NASDAQ: NRXP) is $2.55 last updated October 23, 2026 at 7:39 PM EDT.
There are no upcoming dividends for NRX Pharmaceuticals.
NRX Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for NRX Pharmaceuticals.
NRX Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is...